Sign In
Last checked at 
13 Mar 2014 10:13
ο»Ώ
13 March 2014
Β
CVS Group plc
("CVS" or the "Company")
Β
Exercise of Options
Β
CVS, the UK's leading providers of veterinary services, announces that, on 12 March 2014, it approved the allotment and issue of 4,559 new ordinary shares of 0.2p each in the Company ("Ordinary Shares") (the "New Shares") following the exercise of certain Save As You Earn options by a former CVS employee.
The New Shares will rank pari passu with all existing Ordinary Shares. Application will be made for admission of the New Shares to trading on AIM and dealings are expected to commence on 19 March 2014 ("Admission").
Β
Following Admission, the Company's total issued share capital will consist of 58,213,515 Ordinary Shares with one voting right per share.
Β
The Company does not hold any Ordinary Shares in Treasury.
Β
Therefore, following Admission, the total number of voting rights in the Company will be 58,213,515. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure and Transparency Rules.
Β
Β
Contacts:
Β
CVS Group plc Simon Innes, Chief Executive Nick Perrin, Finance Director Β | Tel: 01379 644 288 Β |
N+1 Singer - Nominated Adviser & Broker Aubrey Powell Alex Wright Β | Tel: 020 7496 3000 Β |
Β
Follow the stocks
